Is DRIO or TIL more profitable?

DRIO runs the higher net margin — DRIO at 322.77% versus TIL at 0.00%.

How have DRIO and TIL total returns compared?

Over the past 5 years, DRIO delivered -52.92% and TIL delivered -54.60% annualized total return. Past performance doesn't predict future results.

DarioHealth Corp. (DRIO) vs Instil Bio, Inc. (TIL)

A side-by-side comparison of DarioHealth Corp. and Instil Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DRIO

DarioHealth Corp.

$44M

$6.06HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT

TIL

Instil Bio, Inc.

$47M

$6.90HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT

Total return — DRIO vs TIL

growth of $100 · dividends reinvested · last 6y

DRIO -98.5% (-50.5%/yr)TIL -98.7% (-51.4%/yr)DRIO compounded faster over this window

DRIO TIL

DRIO vs TIL: by the numbers

•TIL is the larger company ($47M vs $44M market cap).
•DRIO is profitable (322.77% net margin) while TIL runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	DRIO	TIL
P/E ratio	8.78	N/A
P/S ratio	2.11	N/A
P/B ratio	0.80	0.44

Profitability

Metric	DRIO	TIL
Gross margin	56.09%	0.00%
Operating margin	-163.94%	0.00%
Net margin	322.77%	0.00%
ROE	123.04%	-28.20%
ROIC	-78.42%	-18.61%

Growth (annualized)

Metric	DRIO	TIL
Revenue CAGR (5Y)	10.10%	N/A
Total return CAGR (5Y)	-52.92%	-54.60%

Frequently asked

Is DRIO or TIL more profitable?: DRIO runs the higher net margin — DRIO at 322.77% versus TIL at 0.00%.
How have DRIO and TIL total returns compared?: Over the past 5 years, DRIO delivered -52.92% and TIL delivered -54.60% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DRIO analysis Full TIL analysis Interactive comparison tool

Dig into the metrics

DarioHealth P/E ratio DarioHealth ROE Instil Bio ROE DarioHealth operating margin Instil Bio operating margin DarioHealth revenue growth Instil Bio revenue growth DarioHealth free cash flow Instil Bio free cash flow

DarioHealth & Instil Bio appear in these rankings

Highest ROE Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.